Shares of AtriCure (ATRC) have gained 3.5% over the past four weeks to close the last trading session at $37.74, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$51.44 indicates a potential upside of 36.3%.The average comprises nine short-term price targets ranging from a low of $40.00 to a high of$64.00, with a standard deviation of $8.26. While the lowest estimate indicates a ...